Pelclova Daniela, Navratil Tomas, Fenclova Zdenka, Vlckova Stepanka, Kupka Karel, Urban Pavel, Ridzon Petr, Zikan Vit, Landova Ludmila, Syslova Kamila, Kuzma Marek, Kacer Petr
Department of Occupational Medicine of the First Faculty of Medicine and General University Hospital, Charles University Prague, Czech Republic.
Neuro Endocrinol Lett. 2011;32 Suppl 1:71-6.
2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) is a highly toxic persistent environmental contaminant, classified as a human carcinogen affecting any target organ. The mechanism of carcinogenesis by TCDD is unclear as TCDD shows a lack of direct genotoxicity. Experimental studies also support the role of oxidative stress in TCDD neurotoxicity and vascular dysfunction. The aim was to investigate markers of oxidative/nitrosative stress and inflammation using non-invasive methods in subjects who got ill due to severe occupational exposure to TCDD in the years 1965-1968.
In 11 TCDD-exposed patients, and 16 controls, the analysis of following oxidative products of lipids, proteins and nucleic acids in plasma, urine and exhaled breath condensate (EBC) was performed: 8-iso-prostaglandin F2α (8-isoprostane), 4-hydroxy-trans-2-nonenale (HNE), malondialdehyde (MDA), o-tyrosine (o-Tyr), 8-hydroxyguanosine (8-OHG), 8-hydroxy-2´-deoxy-guanosine (8-OHdG), 5-hydroxymethyluracil (5-OHMeU). In addition, nitric-oxide-tyrosine (NO-Tyr) and leukotriene (LT) B4, C4, D4, and E4 were detected by liquid chromatography-mass spectrometry/mass spectrometry (LC-ESI-MS/MS). TCDD was measured by HRGC/HRMS, body lipid content by densitometry. Single-photon emission spectrometry (SPECT) of the brain was performed and compared with the findings of the patients in 2008.
Mean TCDD plasma level in 2010 was 175 ± 162 pg/g lipids (population level about 2 pg/g), total TCDD content in the body 5.16 ± 4.62 mg. Reduction of cerebral blood flow in SPECT progressed in 8 patients, finding was stable in 2 subjects, and improvement occurred in 1 patient. In the EBC, 10 from 12 markers (all except LT D4 and LT E4), were significantly increased in the patients (p<0.05). In the urine, 7 markers were significantly higher than in the controls (p<0.05): 8-isoprostane, MDA, HNE, LT C4, LT E4, o-Tyr and NO-Tyr. In plasma, only NO-Tyr and 8-OHG were elevated (p<0.05).
NO-Tyr was increased in all matrices in dioxin-exposed patients. EBC is not limited to lung disorders as the markers of oxidative stress and inflammation were elevated in EBC of patients with normal lung functions. TCDD-induced oxidative stress and inflammation markers can be detected non-invasively in the EBC and urine in the follow-up of the highly-exposed patients. Their prognostic value, however, needs to be elucidated.
2,3,7,8-四氯二苯并对二恶英(TCDD)是一种剧毒的持久性环境污染物,被列为可影响任何靶器官的人类致癌物。由于TCDD缺乏直接的基因毒性,其致癌机制尚不清楚。实验研究也支持氧化应激在TCDD神经毒性和血管功能障碍中的作用。本研究旨在采用非侵入性方法,对1965年至1968年因严重职业暴露于TCDD而患病的受试者的氧化/亚硝化应激和炎症标志物进行研究。
对11名TCDD暴露患者和16名对照者的血浆、尿液和呼出气冷凝物(EBC)中的脂质、蛋白质和核酸的以下氧化产物进行分析:8-异前列腺素F2α(8-异前列腺素)、4-羟基反式-2-壬烯醛(HNE)、丙二醛(MDA)、邻酪氨酸(o-Tyr)、8-羟基鸟苷(8-OHG)、8-羟基-2'-脱氧鸟苷(8-OHdG)、5-羟甲基尿嘧啶(5-OHMeU)。此外,采用液相色谱-质谱/质谱(LC-ESI-MS/MS)检测一氧化氮酪氨酸(NO-Tyr)和白三烯(LT)B4、C4、D4和E4。采用高分辨气相色谱/高分辨质谱(HRGC/HRMS)测定TCDD,通过密度测定法测量身体脂肪含量。对大脑进行单光子发射光谱(SPECT)检查,并与2008年患者的检查结果进行比较。
2010年TCDD血浆平均水平为175±162 pg/g脂质(人群水平约为2 pg/g),体内TCDD总含量为5.16±4.62 mg。SPECT检查显示,8例患者脑血流量减少,2例患者结果稳定,1例患者有所改善。在EBC中,12种标志物中的10种(除LT D4和LT E4外)在患者中显著升高(p<0.05)。在尿液中,7种标志物显著高于对照组(p<0.05):8-异前列腺素、MDA、HNE、LT C4、LT E4、o-Tyr和NO-Tyr。在血浆中,仅NO-Tyr和8-OHG升高(p<0.05)。
二恶英暴露患者的所有基质中NO-Tyr均升高。EBC不仅限于肺部疾病,因为肺功能正常的患者的EBC中氧化应激和炎症标志物也升高。在高暴露患者的随访中,可以通过EBC和尿液非侵入性检测TCDD诱导的氧化应激和炎症标志物。然而,它们的预后价值尚需阐明。